Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective.

Stanford University School of Medicine:
med.stanford.edu/

1. Is Evidence-Based Medicine a Barrier to Cost-Effective Care?
2. Monoclonal Antibodies: Stanford Academia-Industry Collaboration
3. The Battle of the Diets: Is Anyone Winning (At Losing?)
4. The Mismeasure of Man
5. New Perspectives on Menopausal Hormones and Heart Disease
6. From Sickness to Health: Beethoven's Heiliger Dankgesang
7. Mood Disorders Across Women's Lifecycle
8. Mexican Migrant Health
9. Imaging Patients with Myelopathy
10. Cancer and Climate Change: Parallels in Risk Management
11. The Influence of Sex/Gender on Cardiovascular Health
12. Using Dendritic Cells to Create Cancer Vaccines
13. Environment Degradation Begets Epidemics: Cholera in Bangladesh
14. Vitamin D: It's Not Just For Bones Anymore
15. The Politics and Promise of Stem Cell Research
16. 21st Century Bacterial Pneumonia: Old Habits and New Approaches
17. Maternal Infant Care and Challenges in East Africa
18. Rebuilding Iraq's Mental Health Care System
19. Cancer Biology and Cancer Medicine
20. Childhood Obesity and Public Policy
21. Four Big Ideas from the Carnegie Study on Medical Education
22. Changes in Female Sexual Function Throughout the Lifespan
23. Health Risks of Type-A Behavior
24. The New Rotavirus Vaccine: The Second Time is the Charm

MEDCAST puts you in the front row at some of the leading-edge lectures at the School of Medicine. Tune in to watch Stanford faculty and other renown experts discuss the latest advances in biomedical research, patient care and other health-related fields.

More Information: http://med.stanford.edu/medcast/